Cislini Jeff 4
4 · Revolution Medicines, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Sale
Common Stock
2024-12-16$45.40/sh−1,599$72,601→ 41,628 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 147 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2024.
- [F3]Includes 36,204 RSUs.